BeOne Medicines AG Stock Forecast

Stock Price Forecast

The 11 analysts that cover BeOne Medicines AG stock have a consensus rating of "Buy" and an average price target of $386.45, which forecasts a 29.90% increase in the stock price over the next year. The lowest target is $290 and the highest is $425.

Price Target: $386.45 (+29.90%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$290	$386.45	$400	$425
Change	-2.52%	+29.90%	+34.46%	+42.86%

Analyst Ratings

The average analyst rating for BeOne Medicines AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	4	4	4	3
Buy	8	8	8	7	7	7
Hold	0	0	0	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	12	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yanan Zhu Wells Fargo	Wells Fargo	Buy Initiates $400	Buy	Initiates	$400	+34.46%	May 4, 2026
Kalpit Patel Wolfe Research	Wolfe Research	Buy Initiates $340	Buy	Initiates	$340	+14.29%	Mar 27, 2026
Faisal Khurshid Jefferies	Jefferies	Strong Buy → Hold Downgrades $420 → $290	Strong Buy → Hold	Downgrades	$420 → $290	-2.52%	Mar 16, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $417 → $425	Buy	Maintains	$417 → $425	+42.86%	Feb 27, 2026
Gregory Renza Truist Securities	Truist Securities	Strong Buy Maintains $400 → $412	Strong Buy	Maintains	$400 → $412	+38.49%	Feb 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

44.01B

from 5.34B

723.76%

from 5.34B

Revenue Next Year

50.63B

from 44.01B

15.04%

from 44.01B

EPS This Year

38.65

from 2.47

1,464.71%

from 2.47

EPS Next Year

65.08

from 38.65

68.40%

from 38.65

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.18B	1.42B	2.46B	3.81B	5.34B	44.01B	50.63B
Revenue Growth	280.83%	20.37%	73.65%	54.97%	40.23%	723.76%	15.04%
EPS	-15.71	-19.43	-8.45	-6.12	2.47	38.65	65.08
EPS Growth	-	-	-	-	-	1,464.71%	68.40%
Forward PE	-	-	-	-	-	7.70	4.57
No. Analysts	-	-	-	-	-	16	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	48.7B	57.2B
Avg	44.0B	50.6B
Low	41.0B	45.7B

Revenue Growth

Revenue Growth	2026	2027
High	811.1%	29.9%
Avg	723.8%	15.0%
Low	666.9%	3.8%

EPS Forecast

EPS	2026	2027
High	48.17	94.38
Avg	38.65	65.08
Low	26.54	34.03

EPS Growth

EPS Growth	2026	2027
High	1,850.2%	144.2%
Avg	1,464.7%	68.4%
Low	974.6%	-11.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.